STOCK TITAN

Polinsky Files Final 13D as MCVT Dilutes with $5.42 Private Placement

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Amendment No. 5 to Schedule 13D reports that CEO Douglas M. Polinsky now beneficially owns 680,762 Mill City Ventures III (MCVT) common shares—0.8 % of the outstanding class—falling below the 5 % threshold and triggering this exit filing. His holdings comprise 301,847 directly owned shares and 250,000 currently exercisable options, plus 128,915 shares held through Lantern Advisers, LLC. An additional 622,694 warrant shares are excluded because they are not exercisable within 60 days.

The change stems not from a sale by Mr. Polinsky but from dilution created by the company’s private placement that closed on 31 Jul 2025. The issuer sold 75.88 m shares at $5.42 and issued 7.14 m pre-funded warrants at $5.4199, lifting total shares outstanding to 81.94 m. Polinsky effected no transactions in the past 60 days.

Because his ownership is now below 5 %, this amendment constitutes the final update and exit of his Schedule 13D reporting obligations.

Positive

  • Successful private placement closed on 31 Jul 2025 at $5.42 per share, injecting cash and potentially strengthening MCVT’s balance sheet.

Negative

  • Massive dilution to 81.94 m shares outstanding cut insider ownership to 0.8 %, pressuring existing shareholders’ stakes.
  • Insider exit from 13D reporting reduces future transparency into CEO trading activities.

Insights

TL;DR: Insider stake drops to 0.8 % due to large share issuance, signaling dilution; no shares sold.

The filing is largely mechanical: Polinsky’s percentage fell because MCVT issued ~83 m new securities, expanding the float nearly nine-fold. His absolute stake is unchanged, and he still holds substantial warrants, but his governance influence is now minimal. For investors, the bigger takeaway is the magnitude of dilution implied by the private placement, which may pressure per-share metrics. However, the $5.42 raise could bolster liquidity. Impact is modestly negative given dilution but tempered by fresh capital.

TL;DR: Exit filing reduces insider reporting; board oversight may weaken but free-float rises.

With Polinsky below 5 %, mandatory 13D amendments cease, reducing transparency into his future trades. Insider alignment with minority shareholders diminishes, though broader ownership dispersion can enhance share liquidity and governance checks. No change in control intent is stated. Overall governance impact is neutral to slightly negative.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Footnote for entries 7, 9, 11: Includes (i) 301,847 shares of common stock of the issuer held individually and directly by Mr. Polinsky and (ii) 250,000 shares of common stock of the issuer presently exercisable under a non-statutory stock option. Excludes 622,694 shares of common stock exercisable under warrants issued to Mr. Polinsky by the issuer on July 31, 2025. Pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, the shares of common stock issuable upon exercise of such warrants are not deemed to be beneficially owned by Mr. Polinsky as they are not exercisable within 60 days of the date of the event which triggered this filing. Footnote for entries 7, 8, 9, 10, 11: The reported figures are accurate as of the date of the event requiring the filing of this document, and remain accurate as of the date on which this document is filed. Footnote for entries 8, 10, 11: Consists of 128,915 shares of common stock of the issuer held by Lantern Advisers, LLC ("Lantern"). Lantern is controlled by Mr. Polinsky and Joseph A. Geraci, II, who share voting and dispositive power over the securities held by Lantern and therefore may be deemed to beneficially own the securities held by Lantern. Each of Messrs. Polinsky and Geraci disclaims beneficial ownership of the securities held by Lantern except to the extent of his individual pecuniary interest therein. Footnote for entry 13: As of the date on which this document is filed, the percentage of common stock of the issuer beneficially owned by Mr. Polinsky is 0.8% based on 81,944,398 shares of common stock of the issuer issued and outstanding, as disclosed in the issuer's Current Report on Form 8-K filed on July 31, 2025.


SCHEDULE 13D


POLINSKY DOUGLAS MICHAEL
Signature:/s/ Douglas M. Polinsky
Name/Title:Douglas M. Polinsky/Chief Executive Officer
Date:08/04/2025

FAQ

How many MCVT shares does Douglas M. Polinsky now own?

680,762 shares, including 250,000 options and 128,915 shares via Lantern Advisers.

Why was Amendment No. 5 to Schedule 13D filed?

Polinsky’s ownership fell below 5 % after a large equity offering, requiring an exit filing.

Did Polinsky sell any MCVT shares?

No. The filing states he effected no transactions in the past 60 days; the percentage change is due to dilution.

How many shares did MCVT issue in the July 2025 private placement?

The company sold 75,881,625 common shares and 7,144,205 pre-funded warrants.

What is the current MCVT share count after the offering?

There are 81,944,398 common shares outstanding.